Alpine Immune Sciences SG&A Expense (Quarterly) Insights

Alpine Immune Sciences Inc (ALPN)

64.60 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

64.60 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	6.374M
September 30, 2023	5.443M
June 30, 2023	5.007M
March 31, 2023	5.398M
December 31, 2022	4.389M
September 30, 2022	4.61M
June 30, 2022	4.194M
March 31, 2022	4.775M
December 31, 2021	4.544M
September 30, 2021	3.47M
June 30, 2021	3.29M
March 31, 2021	3.256M
December 31, 2020	3.049M
September 30, 2020	2.728M
June 30, 2020	3.344M
March 31, 2020	1.778M
December 31, 2019	2.102M
September 30, 2019	2.467M
June 30, 2019	2.553M
March 31, 2019	2.345M

Date	Value
December 31, 2018	2.514M
September 30, 2018	1.857M
June 30, 2018	1.883M
March 31, 2018	2.108M
December 31, 2017	1.207M
September 30, 2017	1.932M
June 30, 2017	2.592M
March 31, 2017	2.781M
December 31, 2016	2.168M
September 30, 2016	1.879M
June 30, 2016	2.172M
March 31, 2016	2.367M
December 31, 2015	2.337M
September 30, 2015	1.822M
June 30, 2015	1.387M
March 31, 2015	1.298M
December 31, 2014	0.664M
September 30, 2014	0.49M
June 30, 2014	0.594M
March 31, 2014	0.5393M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.778M

Minimum

Mar 2020

6.374M

Maximum

Dec 2023

3.830M

Average

3.47M

Median

Sep 2021

SG&A Expense (Quarterly) Benchmarks